Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
van den Hoogen LL, Smits G, van Hagen CCE, Wong D, Vos ERA, van Boven M, de Melker HE, van Vliet J, Kuijer M, Woudstra L, Wijmenga-Monsuur AJ, GeurtsvanKessel CH, Stoof SP, Reukers D, Wijsman LA, Meijer A, Reusken CBEM, Rots NY, van der Klis FRM, van Binnendijk RS, den Hartog G.
van den Hoogen LL, et al. Among authors: stoof sp.
Vaccine. 2022 Apr 1;40(15):2251-2257. doi: 10.1016/j.vaccine.2022.03.009. Epub 2022 Mar 9.
Vaccine. 2022.
PMID: 35287986
Free PMC article.